Found 10 results
Author Title [ Type(Desc)] Year
Filters: Author is Fitzsimmons, W  [Clear All Filters]
Journal Article
A. O. Gaber, Moore, L. W., Alloway, R. R., Woodle, E. S., Pirsch, J., Shihab, F., Henning, A., Fitzsimmons, W., Holman, J., Reisfield, R., and First, M. R., Acute Rejection Characteristics From a Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Early Corticosteroid Withdrawal, Transplantation, vol. 95, pp. 573-579, 2013.
T. Gonwa, Ahsan, N., Halloran, P., Stegal, M., Hardy, M., Metzgar, R., Shield, III, C., Rocher, L., Scandling, J., Sorensen, L., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., and Fitzsimmons, W., Comparative trial of Prograf™ (tacrolimus) in combination with azathiprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofeitil after kidney transplantation, 1999.
G. Burke, Kaufman, D., Millis, J., Gaber, A. O., Johnson, C., Sutherland, D., Punch, J., Schweitzer, E., Langnas, A., Perkins, J., Scandling, J., Concepcion, W., Bartucci, M., King, S., Henning, A., and Fitzsimmons, W., The effect of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Three-year results, 2003.
F. S. Shihab, Lee, S. T., Smith, L. D., Woodle, E. S., Pirsch, J. D., Gaber, A. O., Henning, A. K., Reisfield, R., Fitzsimmons, W., Holman, J., First, M. R., and Group, A. Corticoste, Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter Study, Am J Transplant, vol. 13, pp. 474-484, 2013.
J. D. Pirsch, Henning, A. K., First, M. R., Fitzsimmons, W., Gaber, A. O., Reisfield, R., Shihab, F., and Woodle, E. S., New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial, Am J Transplant, vol. 15, pp. 1982-1990, 2015.
N. Ahsan, Johnson, C., Gonwa, T., Halloran, P., Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., and Fitzsimmons, W., Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years, Transplantation, vol. 72, pp. 245-50, 2001.
W. Fitzsimmons, Thompson, D., Hariharan, S., and Van Veldhuisen, P., Serum Creatinine as a Surrogate Endpoint for Graft Loss in Kidney Transplantation Validation Efforts from Multicenter Trials, 2002.
J. Kobashigawa, Miller, L., Russell, S., Ewald, G., Zucker, M., Goldberg, L., Eisen, H., Salm, K., Tolzman, D., Gao, J., Fitzsimmons, W., First, M., and Investigators, S., Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report, Am J Transplant, vol. 6, pp. 1377-1386, 2006.
T. A. Gonwa, Johnson, C., Ahsan, N., ,, Stegall, M., Hardy, M., Metzger, R., Shield, C., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., Scotellaro, P., and Fitzsimmons, W., Untitled, 2000.